{"disease":{"id":"advanced-solid-tumor-and-lymphoma-malignancies","name":"advanced solid tumor and lymphoma malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02000934","title":"A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Calithera Biosciences, Inc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}